Drug Manufacturers Stock News
Categories
- All
- Editor's Picks
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus News Drug Manufacturers
IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Expansion and Diversification
Despite a dip in profitability, IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) focuses on growth through new facilities and increased export revenues. Nov 20, 2024
GuruFocus News Drug Manufacturers
Gufic Biosciences Ltd (BOM:509079) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic Expansions
Despite a dip in quarterly revenue, Gufic Biosciences Ltd (BOM:509079) focuses on strategic growth with new facilities and international market expansions. Nov 19, 2024
GuruFocus News Drug Manufacturers
Dimed SA Distribuidora de Medicamentos (BSP:PNVL3) Q3 2024 Earnings Call Highlights: Strong Digital Growth and Market Expansion Amidst Challenges
Dimed SA reports impressive sales growth and digital advancements, while navigating logistical challenges and competitive pressures in the pharma retail market. Nov 19, 2024
GuruFocus News Drug Manufacturers
Elite Pharmaceuticals Inc (ELTP) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Product Pipeline Expansion
Elite Pharmaceuticals Inc (ELTP) reports significant revenue increases and successful product launches, despite facing competitive and regulatory challenges. Nov 18, 2024